Canopy Growth Corporation (CGC)

The company is renowned for consistently paying a high-yield dividend.

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum. Because of that, Canadian operators with U.S. exposure are drawing attention. Many investors are watching companies positioned for cross-border expansion.

Canopy Growth is a penny stock for a reason, so only the most aggressive investors should even be looking at it.

Canopy Growth is a large marijuana company with an increasingly diversified business. It is also a money-losing penny stock.

There have been many changes and phases to legal cannabis around the globe. With the USA being the biggest market and Canada becoming the first to outright legalize the plant. This has been a slow uphill climb as laws and regulatory matters have made things anything but easy. However, this has not deterred potential investors from seeing an opportunity. Marijuana stocks have offered the average investor or person a chance to enter the space.

Both companies have positioned themselves to capitalize on potential opportunities in the cannabis market. However, there is significant uncertainty ahead, due to regulatory issues (and other concerns) in the industry.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) is pleased to announce that shareholders of MTL Cannabis Corp. (“MTL Cannabis” or “MTL”) have voted to approve the Company's previously announced acquisition of MTL (the “Transaction”) at a special meeting of shareholders of MTL (the “MTL Shareholders”) held February 17, 2026. The plan of arrangement with Canopy Growth received overwhelming support from MTL Shareholders.

The cannabis company's shares have plummeted by more than 40% over the past year.

CGC beats Q3 estimates as Canadian cannabis sales rise, but margin pressure and global volatility cloud its path to sustained profitability.

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy Growth Corporation reported increasing revenue for Q3 2026, but net loss persists. Medical cannabis drove the increase, while international sales decreased. The company will acquire MTL Cannabis, a Quebec operator with two grow facilities, a portfolio of brands, and large online distribution.

Canopy Growth (NASDAQ: CGC) executives said the company made "real progress" in its fiscal third quarter ended Dec. 31, 2025, pointing to a stronger balance sheet, continued growth in Canadian cannabis, and early signs of stabilization in its international operations. Balance sheet strengthened; recapitalization extends maturities CEO Luc Mongeau said Canopy ended the quarter with CAD

Canopy Growth has been a disaster of an investment. Overly aggressive expansion efforts, share dilution, and industry headwinds are to blame.

Canopy Growth Corporation (WEED:CA) Q3 2026 Earnings Call Transcript

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.76 per share a year ago.